Engineered CD47 protects T cells for enhanced antitumour immunity
2024 · Nature · 101 citations
https://doi.org/10.1038/s41586-024-07443-8
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
825
Citations
7
h-index
7
i10-index
Katherine A. Freitas is an academic researcher from Stanford University. The author has contributed to research in topics: CAR-T cell therapy research & Immune Cell Function and Interaction & CRISPR and Genetic Engineering. The author has an h-index of 7, co-authored 17 publications.
ORCID: 0000-0001-9480-7320https://doi.org/10.1038/s41586-024-07443-8
https://doi.org/10.1038/s43018-025-01056-4
Click to start Chat